Key Takeaways
- • CVC Capital Partners IX Aggregator holds 19,189,219 Recordati shares, equal to 9.18% of Recordati's share capital, according to a regulatory disclosure reported by TradingView.
- • The stake disclosure is the sole substantive claim in the available source; the full Reuters article was not accessible in the material provided.
- • The filing signals a continued position in the Italian pharmaceutical company by CVC's private equity vehicle.
Summary
The CVC Capital Partners IX Aggregator, a vehicle associated with CVC Capital Partners' ninth flagship fund, holds 19,189,219 shares in Recordati, representing 9.18% of the Italian pharmaceutical company's share capital, according to a report carried by TradingView and attributed to Reuters.
The available material is limited to the headline and publisher summary. The full article, which would contain additional detail on the timing of the disclosure, transaction history and any changes to the holding, was not accessible in the source provided. Readers seeking the complete context should refer to the original Reuters report.
For institutional investors tracking private equity positions in listed European healthcare companies, the disclosure confirms that CVC's aggregator remains a significant shareholder in Recordati at a level that is material for free float and governance considerations.
The available material is limited to the headline and publisher summary. The full article, which would contain additional detail on the timing of the disclosure, transaction history and any changes to the holding, was not accessible in the source provided. Readers seeking the complete context should refer to the original Reuters report.
For institutional investors tracking private equity positions in listed European healthcare companies, the disclosure confirms that CVC's aggregator remains a significant shareholder in Recordati at a level that is material for free float and governance considerations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.